Buttock Implants in Canada
Buttock Implants in Canada section, includes general infrmation about Buttock Implants Procedure, Canada Buttock Implants Local News, Canada Buttock Implants Surgeon Locator and other Buttock Implants related material.
Canada Buttock Implants - The Plastic Surgery Procedure
This surgical procedure also called gluteoplasty or buttock augmentation. It is designed to reshape the size of your buttocks and create more firm and aesthetic appearance. The buttock area is not easily changed by weight reduction or exercise, therefore you may consider this operation to improve the look of your buttock. In general, every person wishing to undergo the operation, and is in a good physical condition, can do so.
During the operation the surgeon inserts silicon implants into your gluteal area. Unlike breast implants, these are soft and solid, their shape and size vary, according to individual body form and desires.
Canada Buttock Implants - The Implants
There are few kinds of implants: round or oval (also called an anatomic implant). The most common implants are those made of silicon. It comes with a smooth or textured surface and they are solid (meaning: they rarely spill or rupture). The selection of an implant is usually made according to the surgeon's advice and your preference.
Canada Buttock Implants - Insertion Locations
The incision for the implant insertion can be made in several locations: two excisions, either on the superior buttocks or inferior buttock near the posterior thigh. Both incisions leave a quite visible scar. One excision is made in the sacrum area, it goes from top down, and is usually small (4-6cm). The only problem is that such incision tends to become infected more often; this can be treated with antibiotics. The implant can be placed above or below the gluteal muscles. Finally, a liposuction can be added to this procedure to further shape your buttocks.
This procedure is preformed under general anesthesia and usually lasts one hour, liposuction may require an additional half hour (consult local Canada surgeon).
Canada Buttock Implants - Risks
Every procedure has its risks: this one includes bleeding, infection, nerve and/or muscle damage and damage to the implants, such as silicon spillage and buttock asymmetry.
Canada Buttock Implants - After Surgery
After surgery you will feel pain and discomfort, and you will be prescribed with painkillers. You also have to wear a special bandage for 2-3 weeks to help your buttocks gain their new look. Occasionally you may feel either temperature changes or numbness in the area. This will resolve after a few months. It may take about 3 months for the swelling to resolve and the buttocks to regain their final appearance. You'll be able to go back to full activity after one month. Since the implants are placed far from the bony area you will have no trouble sitting. Finally, the implants will give your butt the look like you have been working out for years.
Other Canada Body Procedures
All Body Procedures
Canada Buttock Implants (current)
Canada Buttock Augmentation
Canada Liposuction
Canada Vaginal Surgery
Canada Body Cotouring
More Canada info...
Canada Time zones The Canadian Sir Sandford Fleming first proposed time zones for the entire world in 1876, and Canada is covered coast to coast with multiple zones.
Canada Regions Visiting Canada all in one trip is an ambitious endeavour. When speaking of specific destinations within Canada, it is better to consider its distinct regions.
Atlantic Provinces - maritime culture, small fishing villages, rich folk traditions
Quebec - French-speaking province, stylish and romantic Montreal, festival culture, lush farmland, quaint villages
Ontario - multicultural and vibrant Toronto, the Niagara wine region, the immense Boreal and Taiga forests, Ottawa - the capital, the Great Lakes coastal areas, small rural towns.
Prairies - vast open and flat spaces, rocky mountains, forests, sleepy farm towns, Calgary stampede, and the West Edmonton Mall, Winnipeg Folk Music Festival
British Columbia - cosmopolitan Vancouver city, the rocky mountains, ancient temperate rainforest, pristine wilderness, skiing and hiking opportunities abound
The North - subarctic and arctic wilderness, mountains, glaciers and lakes
Plastic Surgery News...
- According to research published in Pediatrics, fluconazole prophylaxis for extremely low birth weight (ELBW) newborns can reduce the incidence of invasive candidiasis and related mortality in NICUs without causing fluconazole-resistant Candida species
Researchers evaluated the impact of fluconazole prophylaxis for ELBW infants on invasive candidiasis incidence, invasive candidiasis-related mortality rates, and fluconazole susceptibility of Candida isolates. ELBW (401 to 1000 g) infants were eligible if they were younger than 5 days of age and did not have liver failure. Some non-ELBW infants were also given fluconazole if they were considered to be at risk for invasive candidiasis, and fluconazole was given intravenously at a dose of 3 mg/kg at various intervals for up to 6 weeks.
NICU infants (all birth weights) with invasive candidiasis between April 2002 and March 2006 were compared with those with invasive candidiasis before fluconazole prophylaxis (2000-2001).
The following results were reported for the target ELBW infants:
• Invasive candidiasis incidence in NICU infants decreased from 0.6% (19 of 3012 infants) before fluconazole prophylaxis to 0.3% (22 of 6393 infants) in 2002-2006 (p=0.05) and that in extremely low birth weight infants decreased 3.6-fold (from 7.3% to 2%; P = 0 .003).
• Invasive candidiasis-related mortality rate decreased from 2% to 0% (P =0.01), and the all-cause mortality rate decreased from 19% (54 of 3012 infants) to 15% P =0.13).
• The invasive candidiasis species distribution remained stable.
The researchers also conclude that this study demonstrates that fluconazole prophylaxis should be considered in NICUs caring for infants with BWs of less than 1000g or less than 750g, and infants who have significant ongoing risk factors, in a manner that limits total fluconazole exposure.
- Two articles in the ‘Controversies in Cardiovascular Medicine’ series in Circulation discuss whether lowering LDL-cholesterol is an effective strategy to reduce cardiac risk.
The first article challenges healthcare workers to consider the possibility that “the cholesterol-lowering programme has in large part failed to stem the epidemic of CHD and that the well-meaning focus on LDL-C reduction has deflected interest in other therapeutic aspects of lipoprotein treatment that provide equal or greater benefit.” The author reviews the knowledge acquired since 1996 and discusses the following topics.
• Blood cholesterol lowering history
• Relative risk reduction and professional/public confusion
• Statistical significance does not necessarily mean clinical relevance
• NNTs
• The need to go beyond LDL-C reduction and incorporate aspects of reverse cholesterol transport
• HDL-C–raising therapy
• LDL-C–lowering only therapy vs. LDL-C–lowering plus HDL-C–raising therapy trials
The second article outlines the rationale for lowering LDL-C to reduce morbidity and mortality from atherosclerotic cardiovascular disease (ASCVD). The following topics are discussed:
• LDL: the driving force of atherogenesis
• Residual risk beyond LDL lowering
• LDL lowering in secondary prevention
• Primary prevention of ASCVD
The author notes that the major challenge for the medical community is how best to achieve LDL lowering in the general population. He believes that “this will likely require a rethinking of the medical and public health models of prevention and new models almost certainly will include a broader use of inexpensive LDL-lowering drugs but with improved selection of individuals who are likely to benefit.”